Arena Pharmaceuticals, Inc. (ARNA)

[sts66]

OREX is toast - reason for the delay makes it clear - they are going to have a horrible label:

Leerink analyst Marko Kozul wrote in a note Wednesday that the issue revolved around how much of the data from the Light Study has to be disclosed once partner Takeda starts marketing. He emphasized that the FDA was not disputing Orexigen's interpretation of the data, and that similar issues relating to diabetes drugs have been successfully resolved.

Read More At Investor's Business Daily: http://news.investors.com/technology/061114-704247-orex-stock-falls-as-fda-delays-contrave-approval.htm#ixzz34LtGib87
Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook

This is really the reason OREX crashed despite the fact that it's clear the FDA is going to approve.